Related Experiment Video

Updated: Mar 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

ALK alterations and inhibition in lung cancer

Tri Le1, David E Gerber2

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.

Seminars in Cancer Biology
|September 18, 2016
PubMed

Insights

Precision medicine has transformed non-small cell lung cancer (NSCLC) treatment. Anaplastic lymphoma kinase (ALK)-positive NSCLC shows remarkable response to targeted therapies, with ongoing research into resistance and new treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Precision Medicine

Background:

  • Precision medicine revolutionizes non-small cell lung cancer (NSCLC) treatment.
  • Targeted therapies, like kinase inhibitors, show high efficacy in molecularly defined subsets.
  • Anaplastic lymphoma kinase (ALK) rearrangements define a key subset of NSCLC.

Purpose of the Study:

  • To review the current understanding of ALK-positive NSCLC.
  • To summarize pathologic features, diagnostics, and treatment strategies.
  • To explore resistance mechanisms and future research directions.

Main Methods:

  • Literature review of ALK-positive NSCLC.
  • Synthesis of data on biology, pathology, and clinical features.
  • Analysis of targeted therapies, resistance, and future prospects.

Main Results:

  • ALK rearrangements represent a significant oncogenic driver in NSCLC.
  • Rapid development of ALK inhibitors has led to improved patient outcomes.
  • Understanding resistance mechanisms is crucial for advancing treatment.

Conclusions:

  • ALK-positive NSCLC is a well-defined entity within precision oncology.
  • Targeted inhibition of ALK has dramatically improved therapeutic options.
  • Continued research is essential for overcoming treatment resistance and optimizing patient care.
Keywords:
AdenocarcinomaCrizotinibOncogene addictionPersonalized medicinePrecision medicineTargeted therapy

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.4K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K